diabetes glp-1 vs sglt2 Recommendations for SGLT2i versus RA on the basis of kidney For older adults with diabetes,

In March 2026, FDA issued 30 warning letters to telehealth companies marketing compounded GLP-1 products, citing claims that those products were equivalent or comparable to FDA-approved drugs, as well as marketing that blurred the line between approved and unapproved therapies

When members enroll, theyre placed into one of three care pathways based on their eligibility, medical history, and current GLP-1 usage

No creo que debamos esperar que los pacientes puedan enfrentar este proceso por su cuenta, afirm

Medicaid Report

Last month, a Novo spokesperson confirmed to BioSpace that the pharma had filed for approval for oral Wegovy